Esperion Therapeutics, Inc. Financial Ratios — ESPR Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-40.37	-247.4	-60.95	-32.83	-22.69	-27.73	-63.85	-95.81	-54.3	-50.57	-73.24	-74.23	-92.23	-18.83	-5.6
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	100	98.95	81.88	64.27	62.81	79.36	67.95
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	-62.54	-53.11	-288.24	-237.17	-133.58	16.39	14.98
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	-62.75	-53.35	-289.02	-237.83	-133.72	16.37	14.95
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	97.22	8.29
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	-65.49	-63.09	-343.04	-309.58	-179.87	-15.57	-5.17
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	-65.49	-63.09	-343.04	-309.58	-179.87	-15.57	-5.63
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	-65.49	-63.09	-343.04	-309.58	-179.87	-15.57	-5.63
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	7	23	- -	5	4	3	1	- -	2	185	260	261	266	298	252
ST Debt	- -	15	- -	1	2	2	1	- -	- -	3	1	- -	2	57	2
LT Debt	7	8	- -	4	3	1	- -	- -	1	183	259	261	265	240	250
Total Debt/EBITDA	-0.69	-2.26	- -	-0.14	-0.09	-0.04	-0.01	- -	-0.02	-1.53	-1.15	-1.46	-1.71	5.46	4.18
Net Debt/EBITDA	-0.53	-1.62	2.49	2.22	1.47	0.47	0.2	0.18	1.79	1.04	-0.22	-0.75	-1.15	2.71	1.35
Total Debt/EBIT	-0.68	-2.23	- -	-0.13	-0.09	-0.04	-0.01	- -	-0.02	-1.53	-1.15	-1.45	-1.71	5.47	4.18
Net Debt/EBIT	-0.52	-1.59	2.48	2.21	1.46	0.47	0.2	0.18	1.78	1.03	-0.22	-0.75	-1.15	2.71	1.35
EBITDA to Interest Expense	-17.3	-6.77	-24.24	-133.57	-95.78	-189.74	-852.14	-7,297.14	-11.43	-5.33	-4.88	-3.15	-2.63	0.92	0.71
EBITDA-CapEx/Interest Expense	-17.36	-6.78	-24.27	-136.8	-96.4	-189.98	-852.24	-7,302.54	-11.54	-5.92	-4.88	-3.15	-2.63	0.91	0.71
EBIT to Interest Expense	-17.61	-6.87	-24.32	-134.16	-96.23	-190.38	-853.44	-7,306.61	-11.47	-5.35	-4.89	-3.16	-2.64	0.92	0.71
Interest Expense	1	1	1	- -	1	- -	- -	- -	8	23	46	57	59	59	85
Common Equity/Total Assets	-1,386.99	-574.02	-86.91	-72.88	-52.17	-93.46	-142.63	-416.92	-324.2	-237.44	-289.92	-540.44	-752.77	-465.6	-348.47
Long-Term Debt/Equity (%)	- -	- -	- -	3.17	0.94	0.45	- -	- -	5.56	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	1,078.81	157.83	- -	-4.25	-1.79	-0.45	- -	- -	-0.16	-27.98	-30.59	-24.15	-20.62	-18.44	-18.24
Long-Term Debt/Total Assets (%)	316.43	102.96	- -	2.95	0.91	0.42	- -	- -	0.52	51.75	67.82	105.09	128.58	69.89	53.69
Total Debt/Equity (%)	-113.88	-130.94	- -	3.65	1.49	1.19	0.43	- -	7.83	-192.86	-132.12	-80.59	-58.5	-76.56	-83.53
Total Debt/Capital (%)	1,078.81	477.34	- -	-4.89	-2.86	-1.21	-0.26	- -	-0.23	-28.38	-30.75	-24.18	-20.75	-22.84	-18.39
Total Debt/Total Assets (%)	316.43	311.39	- -	3.4	1.45	1.11	0.38	- -	0.73	52.49	68.19	105.25	129.34	86.56	54.14
Net Debt to Equity	-87.94	-93.49	-76.31	-60.03	-25.43	-15.5	-13.66	-46.73	-832.73	130.65	-25.08	-41.73	-39.42	-37.95	-27.03
Net Debt/Capital (%)	-571.65	-933.66	45.38	43.43	32.14	13.39	7.78	5.82	19.32	13.11	-4.68	-11.22	-13.14	-10.19	-5.3
EBITDA	-10	-10	-23	-36	-50	-76	-169	-204	-93	-121	-226	-179	-155	54	60
EBITDA-CapEx	-10	-10	-23	-37	-50	-76	-169	-204	-94	-134	-226	-179	-155	54	60
Operating Income (Loss)	-10	-10	-23	-36	-50	-76	-169	-205	-93	-121	-227	-180	-156	54	60

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	1.17	0.38	14.29	19.28	37.74	13.57	6.04	2.11	3.04	3.24	3.54	1.81	0.53	0.59	0.56
Current Ratio	1.39	0.42	14.42	19.43	38.11	13.7	6.15	2.22	3.2	3.68	4.48	2.67	1.29	1.37	1.54
Quick Ratio	1.17	0.38	14.29	19.28	37.74	13.57	6.04	2.11	3.04	3.37	3.85	2.17	0.84	0.91	1.02
CFO/Avg Current Liab	-2.89	-1.17	-1.69	-6.61	-6.87	-4.5	-5.39	-3.05	-1.08	-1.06	-3.15	-2.11	-1.09	-0.12	-0.05
Common Equity/Total Assets	-1,386.99	-574.02	-86.91	-72.88	-52.17	-93.46	-142.63	-416.92	-324.2	-237.44	-289.92	-540.44	-752.77	-465.6	-348.47
Long-Term Debt/Equity (%)	- -	- -	- -	3.17	0.94	0.45	- -	- -	5.56	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	1,078.81	157.83	- -	-4.25	-1.79	-0.45	- -	- -	-0.16	-27.98	-30.59	-24.15	-20.62	-18.44	-18.24
Long-Term Debt/Total Assets (%)	316.43	102.96	- -	2.95	0.91	0.42	- -	- -	0.52	51.75	67.82	105.09	128.58	69.89	53.69
Total Debt/Equity (%)	-113.88	-130.94	- -	3.65	1.49	1.19	0.43	- -	7.83	-192.86	-132.12	-80.59	-58.5	-76.56	-83.53
Total Debt/Capital (%)	1,078.81	477.34	- -	-4.89	-2.86	-1.21	-0.26	- -	-0.23	-28.38	-30.75	-24.18	-20.75	-22.84	-18.39
Total Debt/Total Assets (%)	316.43	311.39	- -	3.4	1.45	1.11	0.38	- -	0.73	52.49	68.19	105.25	129.34	86.56	54.14
CFO/Total Liabilities	-110.1	-43.75	-430.98	-329.37	-458.99	-287.34	-396.16	-231.04	-36.17	-18.95	-45.6	-30.58	-20.5	-3.23	-1.71
CFO/CapEx	-269.62	-1,544	-584.32	-36.68	-117.4	-507.77	-6,910.63	-984.36	-73.81	-6.37	- -	- -	- -	-74.62	- -
Altman's Z-Score	-35.39	-14.39	14.16	39.86	34.94	8.83	25.26	1.59	0.52	-2.01	-4.86	-8.47	-11.93	-4.37	-2.57

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	36.74	4.44	2.66	2.83	5.17	3.66
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	9.94	82.17	137.01	128.99	70.64	99.74
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.3	0.56	0.77	0.86	0.86	1.29
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,231.11	648.64	470.99	425.28	425.95	281.91
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.46	0.93	1.37	2.69	2.34	2.4
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	796.18	390.76	266.77	135.62	156.1	152.31
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	444.87	340.05	341.23	418.65	340.5	229.35
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1,221.18	-566.47	-333.97	-296.29	-355.31	-182.17
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	16	34	35	66	94	105
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	14	32	27	62	85	99
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	1	7	2	4	5
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	2	2	6	2
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	108	662	490	282	1,576	1,231	1,615	714	145	414	308	412	769
- Cash & Cash Equivalents	2	7	57	85	77	38	34	37	166	305	209	125	82	145	168
+ Preferred Equity and Hybrid Capital	24	24	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	7	23	- -	5	4	3	1	- -	2	185	260	261	266	298	252
Enterprise Value	29	40	48	561	282	73	1,377	1,095	1,416	595	145	508	492	565	853
Total Capital	1	5	-68	-100	-150	-226	-395	-598	-694	-653	-846	-1,079	-1,283	-1,303	-1,371
Total Debt/Capital (%)	1,078.81	477.34	- -	-4.89	-2.86	-1.21	-0.26	- -	-0.23	-28.38	-30.75	-24.18	-20.75	-22.84	-18.39
Total Debt / EV	0.24	0.57	- -	0.01	0.02	0.04	- -	- -	- -	0.31	1.79	0.51	0.54	0.53	0.3
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	9.55	2.61	1.85	6.73	4.23	1.7	2.12
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	10.37	14.14
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	10.38	14.16
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	15.86	10.81
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	15.72	10.81
Diluted Market Cap	- -	- -	108	662	490	282	1,576	1,231	1,615	714	145	414	308	412	769
Diluted Enterprise Value	29	40	52	582	417	247	1,542	1,194	1,451	595	196	550	492	565	853
EV per Share	40.56	55.69	6.12	34.27	12.82	3.26	57.52	40.92	52.28	21.65	5.03	7.65	4.77	3.02	4.11
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	148	228	78	75	116	332	403
TTM EBITDA	-10	-10	-23	-36	-50	-76	-169	-204	-93	-121	-226	-179	-155	54	60
TTM Operating Income	-10	-10	-23	-36	-50	-76	-169	-205	-93	-121	-227	-180	-156	54	60
TTM Cash Flow to Firm	-8	-9	-17	-32	-38	-47	-131	-149	-62	-63	-217	-118	-77	36	79
TTM Free Cash Flow to Firm	-8	-9	-17	-31	-37	-47	-131	-148	-61	-49	-217	-118	-77	36	79

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-5.99	-21.26	-12.96	-5.93	-12	-8.29	-23.28	-9.95	-0.55	-2.37	-2.28	-17.65	-58.74
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	10.38	14.16
Enterprise Value	29	40	48	561	282	73	1,377	1,095	1,416	595	145	508	492	565	853
Low Price	- -	- -	10.9	12.75	18.07	9.4	10.71	33.06	33.13	23.9	4.7	3.28	0.7	1.58	0.69
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	9.55	2.61	1.85	6.73	4.23	1.7	2.12
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	10.37	14.14
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-4.73	-8.63	-27.62	-4.2	-5.8	-7.2	-12.29	-7.84	-2.03	-1.71	-1.14	-8.25	-18.45
Price/Earnings High	- -	- -	-6.08	-19.01	-53.5	-6.74	-9.83	-10.96	-16.77	-14.73	-4.24	-2.52	-3.65	-14.25	-37.85
Price/Earnings Low	- -	- -	-3.29	-5.74	-7.99	-2.83	-1.53	-4.38	-9.24	-4.57	-0.5	-0.93	-0.34	-5.72	-6.35
Price/Book Value	- -	- -	-1.59	-6.34	-3.18	-1.23	-3.98	-2.06	-2.32	-0.85	-0.13	-0.31	-0.2	-0.26	-0.47
Price/Book Value Average	- -	- -	-1.81	-3.01	-8.92	-1.37	-2.45	-2.43	-1.72	-1.34	-0.49	-0.3	-0.15	-0.27	-0.26
Price/Book Value High	- -	- -	-2.33	-6.62	-17.27	-2.21	-4.14	-3.7	-2.34	-2.52	-1.03	-0.44	-0.49	-0.46	-0.53
Price/Book Value Low	- -	- -	-1.26	-2	-2.58	-0.92	-0.65	-1.48	-1.29	-0.78	-0.12	-0.16	-0.05	-0.18	-0.09
Price/Tangible Book Value	- -	- -	1.46	4.96	1.71	1.24	6.44	15.57	81.2	-7.43	-0.73	-1.28	-0.68	-1.06	-2.55
Price/Tangible Book Value Average	- -	- -	1.67	2.35	4.79	1.38	3.96	18.39	60.02	-11.7	-2.77	-1.23	-0.53	-1.1	-1.39
Price/Tangible Book Value High	- -	- -	2.14	5.18	9.27	2.21	6.71	27.98	81.92	-21.99	-5.79	-1.82	-1.68	-1.9	-2.84
Price/Tangible Book Value Low	- -	- -	1.16	1.56	1.39	0.93	1.05	11.19	45.11	-6.83	-0.69	-0.67	-0.16	-0.76	-0.48
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	10.89	3.14	1.84	5.48	2.65	1.24	1.91
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	8.05	4.94	6.96	5.28	2.05	1.29	1.04
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	10.98	9.29	14.55	7.8	6.57	2.22	2.13
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	6.05	2.89	1.73	2.89	0.62	0.89	0.36
Price/Cash Flow	- -	- -	-5.98	-20.68	-12.85	-5.91	-12	-8.28	-22.97	-8.39	-0.55	-2.37	-2.28	-17.41	-58.74
Price/Cash Flow Average	- -	- -	-6.81	-9.81	-36.03	-6.59	-7.38	-9.78	-16.98	-13.21	-2.07	-2.28	-1.76	-18.05	-31.96
Price/Cash Flow High	- -	- -	-8.75	-21.6	-69.81	-10.59	-12.5	-14.88	-23.17	-24.83	-4.33	-3.37	-5.64	-31.18	-65.57
Price/Cash Flow Low	- -	- -	-4.75	-6.52	-10.43	-4.44	-1.95	-5.95	-12.76	-7.71	-0.51	-1.25	-0.53	-12.5	-10.99
Price/Free Cash Flow Average	- -	- -	-6.82	-10.08	-36.34	-6.61	-7.38	-9.79	-17.21	-15.67	-2.07	-2.28	-1.76	-18.3	-31.96
Price/Free Cash Flow High	- -	- -	-8.77	-22.21	-70.41	-10.62	-12.51	-14.9	-23.49	-29.45	-4.33	-3.37	-5.64	-31.6	-65.57
Price/Free Cash Flow Low	- -	- -	-4.75	-6.7	-10.52	-4.45	-1.95	-5.96	-12.93	-9.14	-0.51	-1.25	-0.53	-12.67	-10.99
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	6.94	4.42	7.61	7.09	3.64	1.75	1.25
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	9.88	8.77	15.2	9.61	8.15	2.68	2.34
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	4.94	2.36	2.39	4.69	2.2	1.35	0.57
EV/EBITDA Average	-2.93	-4	-2.94	-6.49	-26.14	-3.68	-5.55	-6.94	-11.1	-8.32	-2.64	-2.99	-2.72	10.65	8.33
EV/EBITDA High	-2.93	-4	-4.49	-16.96	-52.01	-6.2	-9.53	-10.65	-15.79	-16.51	-5.27	-4.05	-6.1	16.35	15.62
EV/EBITDA Low	-2.93	-4	-1.3	-3.57	-6.52	-2.33	-1.32	-4.15	-7.9	-4.44	-0.83	-1.98	-1.65	8.24	3.78
EV/EBIT Average	-2.88	-3.94	-2.94	-6.46	-26.02	-3.67	-5.54	-6.93	-11.06	-8.28	-2.63	-2.98	-2.72	10.66	8.34
EV/EBIT High	-2.88	-3.94	-4.48	-16.88	-51.77	-6.18	-9.52	-10.63	-15.74	-16.44	-5.26	-4.04	-6.09	16.37	15.64
EV/EBIT Low	-2.88	-3.94	-1.29	-3.55	-6.49	-2.32	-1.32	-4.14	-7.87	-4.42	-0.83	-1.97	-1.65	8.25	3.79
Last Price	- -	- -	13.74	40.44	22.26	12.52	65.84	46	59.63	26	5	6.23	2.99	2.2	3.7
High Price	- -	- -	20.1	42.24	120.96	22.43	68.6	82.68	60.16	76.98	39.49	8.87	7.41	3.94	4.13
Enterprise Value Average	29	40	67	234	1,302	279	936	1,417	1,030	1,005	597	535	423	580	503
Enterprise Value High	29	40	102	611	2,590	470	1,608	2,175	1,465	1,995	1,193	725	948	890	943
Enterprise Value Low	29	40	29	129	325	176	223	848	733	537	187	354	256	449	228

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	- -	- -	15	20	23	23	26	27	27	26	61	75	118	196	245
Diluted Weighted Avg Shares	1	1	8	16	22	23	24	27	27	27	29	66	103	187	208
Basic Weighted Avg Shares	1	1	8	16	22	23	24	27	27	27	29	66	103	187	208
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	5.48	8.28	2.71	1.14	1.13	1.78	1.94
EBITDA per Share	-13.82	-13.93	-2.88	-2.2	-2.26	-3.37	-7.05	-7.64	-3.42	-4.4	-7.82	-2.7	-1.51	0.29	0.29
Operating Income per Share	-14.07	-14.12	-2.89	-2.21	-2.27	-3.38	-7.06	-7.65	-3.44	-4.42	-7.84	-2.7	-1.51	0.29	0.29
Basic EPS, GAAP	-14.97	-16.25	-3.31	-2.22	-2.26	-3.33	-6.98	-7.54	-3.59	-5.23	-9.31	-3.52	-2.03	-0.28	-0.11
Basic EPS from Cont Ops	-14.97	-16.25	-3.31	-2.22	-2.26	-3.33	-6.98	-7.54	-3.59	-5.23	-9.31	-3.52	-2.03	-0.28	-0.11
Diluted EPS, GAAP	-14.97	-16.25	-3.31	-2.22	-2.26	-3.33	-6.98	-7.54	-3.59	-5.23	-9.31	-3.52	-2.03	-0.28	-0.11
Diluted EPS from Cont Ops	-14.97	-16.25	-3.31	-2.22	-2.26	-3.33	-6.98	-7.54	-3.59	-5.23	-9.31	-3.52	-2.03	-0.28	-0.11
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-12.55	-14.96	-2.3	-1.96	-1.73	-2.12	-5.49	-5.56	-2.6	-3.1	-9.13	-2.63	-1.31	-0.13	-0.06
Free Cash Flow per Basic Share	-12.6	-14.97	-2.3	-2.01	-1.75	-2.12	-5.49	-5.56	-2.63	-3.59	-9.13	-2.63	-1.31	-0.13	-0.06
Cash & Equivalents per Share	2.17	9.01	7.62	6.46	9.64	9.39	8.36	5.08	7.41	11.1	8.97	2.51	0.8	0.77	0.81
Book Value per Share	-41.85	-58.1	-8.63	-6.38	-7	-10.17	-16.56	-22.35	-25.66	-30.53	-38.28	-20.18	-15.02	-8.55	-7.81
Tangible Book Value per Share	-41.64	-57.33	9.39	8.15	13.04	10.14	10.22	2.96	0.73	-3.5	-6.82	-4.88	-4.41	-2.08	-1.45

Esperion Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)